Logo image of VNE

Veoneer Inc (VNE) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:VNE - Common Stock

36.95
+0.07 (+0.19%)
Last: 3/31/2022, 8:04:26 PM
36.96
+0.01 (+0.03%)
After Hours: 3/31/2022, 8:04:26 PM
Fundamental Rating

2

Taking everything into account, VNE scores 2 out of 10 in our fundamental rating. VNE was compared to 42 industry peers in the Automobile Components industry. VNE has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, VNE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year VNE has reported negative net income.
VNE Yearly Net Income VS EBIT VS OCF VS FCFVNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 -100M -200M -300M -400M -500M

1.2 Ratios

Industry RankSector Rank
ROA -22%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VNE Yearly ROA, ROE, ROICVNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 -10 -20 -30 -40

1.3 Margins

Industry RankSector Rank
OM -20.46%
PM (TTM) -23.23%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VNE Yearly Profit, Operating, Gross MarginsVNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 10 -10 20 -20 -30

More info and screens

2

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, VNE has more shares outstanding
  • VNE has a better debt/assets ratio than last year.
VNE Yearly Shares OutstandingVNE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M 100M
VNE Yearly Total Debt VS Total AssetsVNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 2.01 indicates that VNE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • VNE has a Debt/Equity ratio of 0.27. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z 2.01
ROIC/WACCN/A
WACCN/A
VNE Yearly LT Debt VS Equity VS FCFVNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 500M -500M 1B 1.5B

2.3 Liquidity

  • VNE has a Current Ratio of 1.67. This is a normal value and indicates that VNE is financially healthy and should not expect problems in meeting its short term obligations.
  • A Quick Ratio of 1.33 indicates that VNE should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.33
VNE Yearly Current Assets VS Current LiabilitesVNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 500M 1B 1.5B

More info and screens

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 20.05% over the past year.
  • The Revenue has grown by 20.77% in the past year. This is a very strong growth!
  • The Revenue has been decreasing by -5.67% on average over the past years.
EPS 1Y (TTM)20.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.1%
Revenue 1Y (TTM)20.77%
Revenue growth 3Y-9.4%
Revenue growth 5Y-5.67%
Sales Q2Q%-1.32%

3.2 Future

  • Based on estimates for the next years, VNE will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.01% on average per year.
  • Based on estimates for the next years, VNE will show a quite strong growth in Revenue. The Revenue will grow by 18.15% on average per year.
EPS Next Y45.31%
EPS Next 2Y32.27%
EPS Next 3Y27.67%
EPS Next 5Y15.01%
Revenue Next Year26.64%
Revenue Next 2Y22.93%
Revenue Next 3Y19.71%
Revenue Next 5Y18.15%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VNE Yearly Revenue VS EstimatesVNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
VNE Yearly EPS VS EstimatesVNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3 -4 -5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VNE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for VNE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VNE Price Earnings VS Forward Price EarningsVNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -17.53
VNE Per share dataVNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as VNE's earnings are expected to grow with 27.67% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.27%
EPS Next 3Y27.67%

More info and screens

0

5. Dividend

5.1 Amount

  • VNE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Veoneer Inc

NYSE:VNE (3/31/2022, 8:04:26 PM)

After market: 36.96 +0.01 (+0.03%)

36.95

+0.07 (+0.19%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-02
Earnings (Next)04-27
Inst Owners1.11%
Inst Owner Change0%
Ins Owners0.04%
Ins Owner Change0%
Market Cap4.14B
Revenue(TTM)1.66B
Net Income(TTM)-385.00M
Analysts54
Price Target34 (-7.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.5
P/FCF N/A
P/OCF N/A
P/B 4.85
P/tB N/A
EV/EBITDA -17.53
EPS(TTM)-3.43
EYN/A
EPS(NY)-1.88
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS14.79
BVpS7.61
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -22%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -20.46%
PM (TTM) -23.23%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.67
Quick Ratio 1.33
Altman-Z 2.01
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.1%
EPS Next Y45.31%
EPS Next 2Y32.27%
EPS Next 3Y27.67%
EPS Next 5Y15.01%
Revenue 1Y (TTM)20.77%
Revenue growth 3Y-9.4%
Revenue growth 5Y-5.67%
Sales Q2Q%-1.32%
Revenue Next Year26.64%
Revenue Next 2Y22.93%
Revenue Next 3Y19.71%
Revenue Next 5Y18.15%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Veoneer Inc / VNE FAQ

What is the ChartMill fundamental rating of Veoneer Inc (VNE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to VNE.


What is the valuation status for VNE stock?

ChartMill assigns a valuation rating of 1 / 10 to Veoneer Inc (VNE). This can be considered as Overvalued.


Can you provide the profitability details for Veoneer Inc?

Veoneer Inc (VNE) has a profitability rating of 1 / 10.